Navco Pharmaceuticals (TSXV:NAV) Total Assets : C$0.10 Mil (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Total Assets?

Navco Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2023 was C$0.10 Mil.

During the past 3 years, the average Total Assets Growth Rate was 10.50% per year.

During the past 4 years, Navco Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 10.50%. The lowest was 10.50%. And the median was 10.50%.

Total Assets is connected with ROA %. Navco Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2023 was 33.86%. Total Assets is also linked to Revenue through Asset Turnover. Navco Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2023 was 0.00.

Navco Pharmaceuticals Total Assets Historical Data

The historical data trend for Navco Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Total Assets Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Total Assets

0.10

0.23

0.18

0.12

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Assets	Get a 7-Day Free Trial														0.11	0.11	0.11	0.09	0.10

Navco Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Navco Pharmaceuticals's Total Assets for the fiscal year that ended in Jun. 2021 is calculated as

Total Assets	=	Total Equity (A: Jun. 2021 )	+	Total Liabilities (A: Jun. 2021 )
	=	0.097	+	0.019
	=	0.12

Navco Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2023 )	+	Total Liabilities (Q: Mar. 2023 )
	=	0.004	+	0.091
	=	0.10

Navco Pharmaceuticals (TSXV:NAV) Total Assets Explanation

Total Assets is connected with ROA %.

Navco Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2023 is

ROA %	=	Net Income (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
	=	0.032	/	( (0.094	+	0.095)	/ 2 )
	=	0.032	/	0.0945
	=	33.86 %

Note: The Net Income data used here is four times the quarterly (Mar. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Navco Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2023 is

	Asset Turnover
=	Revenue (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
=	0	/	( (0.094	+	0.095)	/ 2 )
=	0	/	0.0945
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Navco Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.